Glen Harbor Capital Management’s GSK GSK Stock Holding History

Glen Harbor Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-8,061	Closed	-$405K	–	1306
2018 Q3	$405K	Hold	8,061	–	–	0.01%	802
2018 Q2	$406K	Hold	8,061	–	–	0.01%	714
2018 Q1	$394K	Hold	8,061	–	–	0.01%	725
2017 Q4	$357K	Hold	8,061	–	–	0.01%	775
2017 Q3	$409K	Hold	8,061	–	–	0.01%	654
2017 Q2	$434K	Hold	8,061	–	–	0.01%	628
2017 Q1	$425K	Hold	8,061	–	–	0.01%	597
2016 Q4	$388K	Buy	+8,061	New	+$398K	0.01%	562

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Glen Harbor Capital Management's GSK Position: Q4 2018 in Review

Glen Harbor Capital Management sold out of GSK (GSK) in Q4 2018, closing a stake of 8,061 shares — an estimated $405K sold.

Glen Harbor Capital Management first reported a position in GSK in Q4 2016 and held it in 8 quarters. The position peaked at $434K in Q2 2017. 799 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

Glen Harbor Capital Management reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
Glen Harbor Capital Management sold 8,061 GSK shares in Q4 2018, an estimated $405K.
Glen Harbor Capital Management first reported a position in GSK in Q4 2016 and held it in 8 quarters.
Glen Harbor Capital Management's GSK position peaked at $434K in Q2 2017.
799 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on Glen Harbor Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.